Table 1.
Baseline characteristics of study population
| PMI (n=45) | RMI (n=30) | CSA (n=30) | p value | |||
|---|---|---|---|---|---|---|
| Age, y | 61.0 (15.0) | 62.5 (18.0) | 63.0 (8.0) | 0.800 | ||
| Men, n (%) | 38 (84.4) | 26 (86.7) | 24 (80.0) | 0.841 | ||
| BMI, kg/m2 | 25.2 ± 3.8 | 25.3 ± 3.3 | 25.9 ± 3.0 | 0.645 | ||
| Hypertension, n (%) | 23 (53.5) | 17 (56.7) | 21 (70.0) | 0.344 | ||
| Diabetes, n (%) | 16 (37.2) | 17 (56.7) | 16 (53.3) | 0.223 | ||
| Dyslipidemia, n (%) | 19 (44.2) | 11 (36.7) | 11 (36.7) | 0.788 | ||
| Smoking, n (%) | 17 (37.8) | 19 (63.3) | 11 (36.7) | 0.061 | ||
| Total cholesterol, mg/dL | 3.92 (1.66) | 3.77 (0.71) | 3.87 (1.25) | 0.664 | ||
| Triglycerides, mg/dL | 1.37 (0.58) | 1.77 (0.85) | 1.49 (0.66) | 0.129 | ||
| HDL-C, mg/dL | 0.93 (0.32) | 0.93 (0.30) | 0.89 (0.25) | 0.634 | ||
| LDL-C, mg/dL | 2.30 (1.06) | 2.14 (0.91) | 2.23 (0.98) | 0.255 | ||
| WBC, × 109/μL | 8.41 (3.93) | 8.39 (4.14) | 7.34 (1.85) | 0.145 | ||
| Neutrophil | 6.50 (5.12) | 5.33 (3.39) | 4.92 (1.26) | 0.100 | ||
| CRP, mg/L | 3.40 (4.68) | 2.54 (4.43) | 1.81 (2.37) | 0.118 | ||
| hsTnI, pg/mL | 28.5 (105.0) | 32.7 (41.0) | 11.9 (34.0) | 0.152 | ||
| CK-MB,ng/mL | 1.90 (3.88) | 2.10 (1.85) | 1.80 (1.78) | 0.336 | ||
| BNP, pg/mL | 311.0 (248.0) | 332.0 (328.0) | 236.0 (205.0) | 0.234 | ||
| Revascularization | 33 (73.3) | 22 (73.3) | 21 (70.0) | 0.961 | ||
BMI = body-mass index; BNP = Brain natriuretic peptide; CK-MB = creatine kinase-MB; CSA = chronic stable angina; CRP = C-reactive protein; HDL-C = high-density lipoprotein cholesterol; hsTnI = high-sensitive Troponin I; LDL-C = low-density lipoprotein cholesterol; PMI, primary myocardial infarction; RMI, recurrent myocardial infarction; WBC, white blood cell